Scientus Pharma unites research & development and full commercial production facilities into one integrated organization.
Our research operations are headquartered at the MaRS Discovery District in Toronto, widely considered the preeminent life sciences hub in Canada and amongst the finest in the world. MaRS spearheads an optimal environment for start-up success by providing early-stage seed investing for science and tech companies looking to get to market faster.
We also have full access to multiple research facilities through our relationship with the University Health Network, the largest biomedical research institution in the country and one of the largest in the world. Chief amongst them is the Center for Molecular Design and Preformulations (CMDP) where Scientus conducts research utilizing $25M of sophisticated lab equipment. It should be noted that all the lab equipment is rented in a true pharma grade facility, enabling us to keep start-up costs relatively low.
Scientus also owns and operates a 45,000 Sq. Ft. commercial production facility, 45 minutes from downtown Toronto. This facility provides a flexible pharmaceutical platform in full compliance with Health Canada’s quality and regulatory requirements. It also houses a fully equipped analytical and biological testing laboratory that allows Scientus to conduct additional internal and external research and development. With this facility, Scientus is also a final stage applicant under Health Canada’s ACMPR licensing.